Scientific paper - review paper
Impact of Reslizumab on Outcomes of Severe Asthmatic Patients: Current Perspectives

Padilla Galo, Alicia; Labor, Marina; Tiotiu, Angelica; Baiardini, Ilaria; Scichilone, Nicola; Braido, Fulvio (2018)
Cite this document

Padilla Galo, A., Labor, M., Tiotiu, A., Baiardini, I., Scichilone, N. & Braido, F. (2018). Impact of Reslizumab on Outcomes of Severe Asthmatic Patients: Current Perspectives. Patient Related Outcome Measures, 9., 267-273. doi: 10.2147/PROM.S146966

Padilla Galo, Alicia, et al. "Impact of Reslizumab on Outcomes of Severe Asthmatic Patients: Current Perspectives." Patient Related Outcome Measures, vol. 9, 2018, pp. 267-273. https://doi.org/10.2147/PROM.S146966

Padilla Galo, Alicia, Marina Labor, Angelica Tiotiu, Ilaria Baiardini, Nicola Scichilone and Fulvio Braido. "Impact of Reslizumab on Outcomes of Severe Asthmatic Patients: Current Perspectives." Patient Related Outcome Measures 9 (2018): 267-273. https://doi.org/10.2147/PROM.S146966

Padilla Galo, A., et al. (2018) 'Impact of Reslizumab on Outcomes of Severe Asthmatic Patients: Current Perspectives', Patient Related Outcome Measures, 9, pp. 267-273. doi: 10.2147/PROM.S146966

Padilla Galo A, Labor M, Tiotiu A, Baiardini I, Scichilone N, Braido F. Impact of Reslizumab on Outcomes of Severe Asthmatic Patients: Current Perspectives. Patient Related Outcome Measures [Internet]. 2018 [cited 2019 November 18];9:267-273. doi: 10.2147/PROM.S146966

A. Padilla Galo, M. Labor, A. Tiotiu, I. Baiardini, N. Scichilone and F. Braido, "Impact of Reslizumab on Outcomes of Severe Asthmatic Patients: Current Perspectives", Patient Related Outcome Measures, vol. 9, pp. 267-273, 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:239:222855. [Accessed: 18 November 2019]